AU2002313236A1 - Medicinal compositions - Google Patents

Medicinal compositions

Info

Publication number
AU2002313236A1
AU2002313236A1 AU2002313236A AU2002313236A AU2002313236A1 AU 2002313236 A1 AU2002313236 A1 AU 2002313236A1 AU 2002313236 A AU2002313236 A AU 2002313236A AU 2002313236 A AU2002313236 A AU 2002313236A AU 2002313236 A1 AU2002313236 A1 AU 2002313236A1
Authority
AU
Australia
Prior art keywords
medicinal compositions
medicinal
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2002313236A
Other versions
AU2002313236B8 (en
AU2002313236B2 (en
Inventor
Kazutaka Higaki
Toshikiro Kimura
Takanori Minami
Masateru Miyake
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Priority claimed from PCT/JP2002/005954 external-priority patent/WO2002102414A1/en
Publication of AU2002313236B8 publication Critical patent/AU2002313236B8/en
Publication of AU2002313236A1 publication Critical patent/AU2002313236A1/en
Application granted granted Critical
Publication of AU2002313236B2 publication Critical patent/AU2002313236B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2002313236A 2001-06-14 2002-06-14 Medicinal compositions Ceased AU2002313236B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2001-180373 2001-06-14
JP2001180373 2001-06-14
JP2001298839 2001-09-28
JP2001-298839 2001-09-28
PCT/JP2002/005954 WO2002102414A1 (en) 2001-06-14 2002-06-14 Medicinal compositions

Publications (3)

Publication Number Publication Date
AU2002313236B8 AU2002313236B8 (en) 2003-01-02
AU2002313236A1 true AU2002313236A1 (en) 2003-05-15
AU2002313236B2 AU2002313236B2 (en) 2007-07-26

Family

ID=26616910

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002313236A Ceased AU2002313236B2 (en) 2001-06-14 2002-06-14 Medicinal compositions

Country Status (9)

Country Link
US (3) US6884768B2 (en)
EP (2) EP1407785A4 (en)
KR (3) KR20090019915A (en)
CN (2) CN100350977C (en)
AU (1) AU2002313236B2 (en)
CA (2) CA2662967C (en)
MX (1) MXPA03011538A (en)
TW (1) TWI239247B (en)
WO (1) WO2002102414A1 (en)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE44578E1 (en) 2000-04-10 2013-11-05 Teva Pharmaceutical Industries, Ltd. Stable pharmaceutical compositions containing 7-substituted-3,5-dihydroxyheptanoic acids or 7-substituted-3,5-dihydroxyheptenoic acids
US20050032811A1 (en) 2003-08-06 2005-02-10 Josiah Brown Methods for administering aripiprazole
WO2005023225A1 (en) * 2003-09-05 2005-03-17 Ranbaxy Laboratories Limited Cilostazol adsorbate
JP4836797B2 (en) 2003-10-23 2011-12-14 大塚製薬株式会社 Controlled release sterile injection aripiprazole formulations and methods
HUE038247T2 (en) 2004-05-19 2018-10-29 Los Angeles Biomedical Res Inst Harbor Ucla Medical Ct Injectable coposition comprising sodium deoxycholate
US7754230B2 (en) * 2004-05-19 2010-07-13 The Regents Of The University Of California Methods and related compositions for reduction of fat
US20060127468A1 (en) * 2004-05-19 2006-06-15 Kolodney Michael S Methods and related compositions for reduction of fat and skin tightening
US20140162965A1 (en) 2004-08-25 2014-06-12 Aegis Therapeutics, Inc. Compositions for oral drug administration
US9895444B2 (en) 2004-08-25 2018-02-20 Aegis Therapeutics, Llc Compositions for drug administration
US9114069B2 (en) * 2004-08-25 2015-08-25 Aegis Therapeutics, Llc Antibacterial compositions for drug administration
US20110257096A1 (en) * 2004-08-25 2011-10-20 Aegis Therapeutics, Inc. Compositions for drug administration
US20090047347A1 (en) * 2005-07-29 2009-02-19 Aegis Therapeutics, Inc. Compositions for Drug Administration
US20060046962A1 (en) 2004-08-25 2006-03-02 Aegis Therapeutics Llc Absorption enhancers for drug administration
WO2006030301A1 (en) * 2004-09-17 2006-03-23 Ranbaxy Laboratories Limited Cilostazol- containing pharmaceutical composition based on particles of less than 50 micrometers
TWI363626B (en) * 2004-11-15 2012-05-11 Otsuka Pharma Co Ltd Aqueous ophthalmic suspension of crystalline rebamipide
CA2622758A1 (en) 2005-09-15 2007-03-29 Elan Pharma International, Limited Nanoparticulate aripiprazole formulations
US8920918B2 (en) * 2005-10-31 2014-12-30 Kee Action Sports Technology Holdings, Llc Oil and polyethylene glycol fill material for use in paintball shells
TW200808375A (en) * 2006-05-12 2008-02-16 Otsuka Pharma Co Ltd Hydrogel suspension and manufacturing process thereof
US8226949B2 (en) 2006-06-23 2012-07-24 Aegis Therapeutics Llc Stabilizing alkylglycoside compositions and methods thereof
US20080075785A1 (en) * 2006-09-22 2008-03-27 San-Laung Chow Controlled release hydrogel formulation
US20110165236A1 (en) * 2006-09-22 2011-07-07 Biokey, Inc. Controlled release hydrogel formulation
TWI415629B (en) * 2006-10-26 2013-11-21 Otsuka Pharma Co Ltd Aqueous pharmaceutical suspensions containing rebamipide and manufacturing process thereof
EP2167068A2 (en) * 2007-07-05 2010-03-31 Inserm-Institut National De La Sante Et De La Recherche Medicale Anticonvulsive pharmaceutical compositions
EP2011491A1 (en) * 2007-07-05 2009-01-07 Institut National De La Sante Et De La Recherche Medicale (Inserm) Anticonvulsive pharmaceutical compositions
AR067747A1 (en) 2007-07-31 2009-10-21 Otsuka Pharma Co Ltd METHODS TO PRODUCE SUSPENSION OF ARIPIPRAZOL AND LIOFILIZED FORMULATION
EP2180882B2 (en) * 2007-10-19 2017-06-28 Otsuka Pharmaceutical Co., Ltd. Solid matrix pharmaceutical preparation
ES2586032T3 (en) 2008-03-28 2016-10-11 Hale Biopharma Ventures, Llc Administration of benzodiazepine compositions
EP2165702B1 (en) 2008-09-17 2011-11-16 Helm AG Stable and readily dissolved compositions of candesartan cilexetil prepared with wet granulation
US8440631B2 (en) 2008-12-22 2013-05-14 Aegis Therapeutics, Llc Compositions for drug administration
US8101593B2 (en) 2009-03-03 2012-01-24 Kythera Biopharmaceuticals, Inc. Formulations of deoxycholic acid and salts thereof
EP2418945B1 (en) * 2009-04-15 2018-12-05 BMG PHARMA S.p.A. Mineral salt-sulfonic acid compositions and methods of use
CN102145003B (en) * 2010-02-08 2015-04-22 张立英 Medicinal composition containing insoluble medicament
EP2608781A4 (en) * 2010-08-04 2014-01-29 Tixupharma Inclusion complexes of cyclodextrins with spermidine, and proliferative/reparative compositions comprising thereof
PL2898881T3 (en) * 2010-08-04 2019-04-30 Pierrel Pharma S R L Compositions comprising supramolecular complexes of polyanionic polymers and spermidine for use in the treatment of periodontum and damaged oral tissue
KR101277021B1 (en) * 2010-12-28 2013-06-24 주식회사 드림파마 Oral controlled release double-layered rebamipide-contained formulation using gastro-retentive drug delivery system and process for the preparation thereof
MX363465B (en) 2011-02-18 2019-03-25 Kythera Biopharmaceuticals Inc Treatment of submental fat.
US8653058B2 (en) 2011-04-05 2014-02-18 Kythera Biopharmaceuticals, Inc. Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits
ES2917973T3 (en) 2011-06-14 2022-07-12 Neurelis Inc Benzodiazepine administration
CN102357084B (en) * 2011-10-11 2014-02-26 广东彼迪药业有限公司 Enalapril maleate tablet composition and its preparation and use
US10918612B2 (en) * 2013-01-22 2021-02-16 Markus Zwickl Combinations with 2-aminoethanesulfonic acid
US20160136282A1 (en) * 2014-11-18 2016-05-19 Genovate Biotechnology Co., Ltd. Novel formulation of cilostazol, a quinolinone-derivative used for alleviating the symptom of intermittent claudication in patients with peripheral vascular disease
PE20180690A1 (en) 2015-04-27 2018-04-23 Intercept Pharmaceuticals Inc OBETICOLIC ACID COMPOSITIONS AND METHODS OF USE

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4591605A (en) 1981-11-10 1986-05-27 Research Foundation Of State University Of New York Method and ingestible formulation for inhibiting the secretion of stomach acid
NZ212053A (en) * 1984-05-17 1988-02-29 Merrell Dow Pharma Polyamine containing pharmaceutical compositions for treating neoplasms
JP2911496B2 (en) * 1989-09-11 1999-06-23 帝國製薬株式会社 Highly absorbable vaginal agent containing bioactive polypeptide
JPH03275633A (en) * 1990-03-23 1991-12-06 Teikoku Seiyaku Co Ltd Absorbefacient for physiologically active polypeptide
US5328844A (en) * 1990-05-09 1994-07-12 University Of Colorado Foundation, Inc. Culture media for mammalian cells
JPH0733667A (en) * 1992-07-03 1995-02-03 Japan Tobacco Inc Aqueous solution of 4,6-o-hydroxyphosphorylglucosamine derivative and method of making the same derivative water-soluble
JPH0656643A (en) * 1992-08-03 1994-03-01 Shiseido Co Ltd Skin preparation for external use
JPH06192108A (en) * 1992-12-25 1994-07-12 Kanebo Ltd Calcium gluconate oral solution
JP3690820B2 (en) 1993-02-25 2005-08-31 雪印乳業株式会社 Nutritional composition for infants
SE9404196D0 (en) 1994-12-02 1994-12-02 Astra Ab New antithrombotic formulation
JP3297969B2 (en) * 1994-12-26 2002-07-02 ライオン株式会社 Eye drops
AU4357096A (en) 1995-01-10 1996-07-31 Otsuka Pharmaceutical Co., Ltd. Resin particle, medical material and pharmaceutical preparation containing said resin particle
WO1996023490A1 (en) * 1995-02-03 1996-08-08 Cosmederm Technologies Formulations and methods for reducing skin irritation
JPH1025255A (en) * 1996-07-11 1998-01-27 Taisho Pharmaceut Co Ltd Scarcely soluble agent improved in solubility
JP3677376B2 (en) * 1996-08-13 2005-07-27 武田薬品工業株式会社 Medicine
JPH10262607A (en) 1997-03-28 1998-10-06 Snow Brand Milk Prod Co Ltd Nutrient composition for infant
JPH1160487A (en) * 1997-06-09 1999-03-02 Taisho Pharmaceut Co Ltd Vitamin b1 derivative-formulated solution
JPH1160486A (en) * 1997-06-09 1999-03-02 Taisho Pharmaceut Co Ltd Thiamin-mixed liquid formulation
JP4403590B2 (en) * 1997-10-02 2010-01-27 大正製薬株式会社 Vitamin B1 combination liquid
JP4390030B2 (en) * 1997-12-03 2009-12-24 大正製薬株式会社 Minoxidil combination liquid composition
EP1113785B1 (en) * 1998-07-24 2005-04-13 Seo Hong Yoo Clear aqueous solutions of bile acids
US6207190B1 (en) * 1998-08-13 2001-03-27 Chronorx, Llc Dosage forms for the treatment of the chronic glaucomas

Similar Documents

Publication Publication Date Title
AU2002313236A1 (en) Medicinal compositions
AU781269C (en) Pharmaceutical compositions
EP1407785A4 (en) Medicinal compositions
HK1065944A1 (en) Medicinal compositions
AU2001250420A1 (en) Pharmaceutical compositions
AU2001274307A1 (en) Pharmaceutical compositions
AU2002302147A1 (en) Pharmaceutical composition
AU2002258221A1 (en) Medicinal composition
AU2002214324A1 (en) Medicinal compositions
AU2001273919A1 (en) Pharmaceutical compositions
AU2002365093A1 (en) Therapeutic compositions
AUPR600601A0 (en) Therapeutic compositions
AU2002321808A1 (en) Dental compositions
AU2002354460A1 (en) Medicinal composition
AUPR529701A0 (en) Pharmaceutical composition
AU2001282541A1 (en) Medicinal compositions
AU2002346223A1 (en) Medicinal compositions
AU2001285737A1 (en) Pharmaceutical compositions
EP1413314A4 (en) Medicinal compositions
AU2002256916A1 (en) Medicinal compositions
AU2002327341A1 (en) Thrombomodulin-containing medicinal compositions
AU2002306341A1 (en) Medicinal compositions
AU2002226759A1 (en) Medicinal composition
AU2002326822A1 (en) Pro-micelle pharmaceutical compositions
AU2002100921A4 (en) Pharmaceutical composition